zepbound lilly - Search News

Eli Lilly cuts prices for Zepbound weight-loss drug

CNN on MSN · 4h

Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the United States, shoring up domestic manufacturing as President Donald Trump threatens new tariffs on pharmaceuticals.

Hosted on MSN · 22h

Eli Lilly cuts prices for Zepbound weight-loss drug again

Pharmaceutical giant Eli Lilly is once again expanding the supply of its weight-loss drug Zepbound and cutting the cost for patients that don't have insurance.

The Wall Street Journal on MSN · 22h

Eli Lilly to Offer Higher Doses of Obesity Drug Zepbound at Discounted Prices

Eli Lilly said it has launched new doses of its obesity treatment drug and reduced its prices.

BioPharma Dive4h

Lilly expands US manufacturing build-out with $50B target

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...

Lilly expands its Zepbound vial offering, as Hims pulls back on semaglutide

Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and other biotech news in today's Readout ...

With $27B plan to build 4 new plants, Eli Lilly doubles down on US drug manufacturing

Over the last few years, as Eli Lilly has revealed a series of manufacturing investments—each one seemingly more lavish than ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results